Economic evaluation of a 100 whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children

Current Medical Research and Opinion

Volumn 26, Issue 11, 2010, Pages 2607-2626

  Iskedjian, Michael ^a,b,c   Dupont, Christophe ^d   Spieldenner, Jörg ^e   Kanny, Gisle ^f   Raynaud, Françoise ^g   Farah, Bechara ^a   Haschke, Ferdinand ^e,h  

^a PharmIdeas Research and Consulting Inc   (Canada)

^b PharmIdeas Europe SAS   (France)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d HÔPITAL SAINT VINCENT DE PAUL   (France)

^e NESTLÉ RESEARCH CENTER   (Switzerland)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergy; Atopic dermatitis; Cost effectiveness analysis; Economic; Infant formula; Infant nutrition; Prevention

Indexed keywords

ARTICLE; ARTIFICIAL MILK; ATOPIC DERMATITIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; FRANCE; HEALTH CARE COST; HIGH RISK PATIENT; REIMBURSEMENT; SENSITIVITY ANALYSIS; STATISTICAL MODEL; WHEY;

ALGORITHMS; COST-BENEFIT ANALYSIS; DERMATITIS, ATOPIC; DIETARY PROTEINS; ECONOMICS, PHARMACEUTICAL; FRANCE; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; META-ANALYSIS AS TOPIC; MILK PROTEINS; PROTEIN HYDROLYSATES;

EID: 77958131496     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.525472     Document Type: Article

References (29)

1. Socié té Française de Dermatologie. Prise en charge de la dermatite atopique de l'enfant. Texte des recommandations. Annal Dermatol Véné réol 2005; 132:1S9-1S18
2. Spergel J, Paller A. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112(6 Suppl):S118-27
3. Schulz Larsen F, Hanifin J. Epidemiology of atopic dermatitis. Immunol Allergy Clini North Am 2002;22:1-24
4. Bergmann R, Edenharter G, Bergmann K, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998; 28:965-70
5. Halken S. Allergy Review Series VI: The immunology of fetuses and infants. The lessons of noninterventional and interventional prospective studies on the development of atopic disease during childhood. Allergy 2000;55: 793-802
6. Exl B-M. A review of recent developments in the use of moderately hydrolyzed whey formulae in infant nutrition. Nutr Res 2001;21:355-79
7. Von Berg A, Koletzko S, Filipiak-Pittroff B, et al. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: The German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol 2003;111:533-40
8. World Health Organization and United Nations Children's Fund. Global Strategy for Infant and Young Child Feeding. Geneva: NLM Classification: WS 120,2003
9. Von Berg A, Koletzko S, Filipiak-Pittroff B, et al. Certian hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol 2007;119:718-25
10. Von Berg A, Filipiak-Pittroff B, Krämer U, et al. Preventative effect of hydro-lyzed formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 2008; 121:1442-7
11. Szajewska H, Horvath A. Meta-analysis of the evidence for a partially hydro-lyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin 2010;26:423-37
12. Alexander D, Cabana M. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis. Journal of Pediatr Gastroenterol Nutr 2010;50:422-30
13. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006;60:984-92
14. Ricci G, Bendandi B, Pagliara L, et al. Atopic dermatitis in Italian children: evaluation of its economic impact. J Pediatr Health Care 2006;20: 312-15
15. Gieler U, Hohmann M, Niemeier V, et al. Cost evaluation in atopic eczema. J Dermatol Treat 1999;10(Suppl 1):S15-20
16. Weinmann S, Kamtsiuris P, Wickman H, et al. The costs of atopy and asthma in children: assessment of direct costs and their determinants in a birth cohort. Pediatr Allergy Immunol 2003;14:18-26
17. Drummond M, Sculpher M, Torrance G, et al. Cost Analysis. In: Drummond M, Sculpher M, Torrance G, et al., eds. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford, UK: Oxford University Press, 2006:55-101
18. Luce BR, Manning WG, Siegel JE, et al. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, et al., eds. Cost-Effectiveness in Health and Medicine, 1st edn. Oxford, UK: Oxford University Press, 1996:176-213
19. Iskedjian M, Szajewska H, Spieldenner J, et al. Extension of a meta-analysis of the evidence for a partially hydrolyzed 100%-whey formula in the prevention of atopic dermatitis: brief research report. Curr Med Res Opin 2010;26: 2599-2606
20. Iskedjian M, De Serres G, Einarson T, et al. J. Economic impact of the intruduction of an accellular pertussis vaccine in Canada: a 6-year analysis. Vaccine 2010;28:714-23
21. Pison G. France 2008: why are birth numbers still rising? Population & Societies 2009; March: No. 454
22. Branger B, Cebron M, Picherot G, et al. Facteurs influençant la durée de l'allaitement maternel chez 150 femmes. Arch Pé diatr 1998;5: 489-96
23. Turck D, Comité de nutrition de la Socié té Française de Pé diatrie. Allaitement maternel: les bé né fices pour la santé de l'enfant et de sa mè re. Arch Pé diatr 2005;12:S145-65
24. Oranje A, Glazenburg E, Wolkerstorfer A, et al. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol 2007;157:645-8
25. Table de Mortalité des Années 2004-2006. Institut national de la statistique et des études économiques. Available at: http://www.insee.fr/en/ [Last accessed 9 February 2010]
26. Cost of physician visits in France. Assurance maladie en ligne. Available at: http://www.ameli.fr/assures/soins-et-remboursements/combien-serez-vous- rembourse/consultations/les-consultations-en-metropole/les-enfants-de-moins-de- 16-ans.php [Last accessed 5 February 2010]
27. Average monthly gross wage for nurses in France. La coordination nationale infirmiè re. Available at: http://www.coordination-nationale- infirmiere.org/index.php/Grille-des-salaires/#ancre4 [Last accessed 5 February 2010]
28. Pitt M, Garside R, Stein K. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema. Br J Dermatol 2006;154:1137-46
29. Coyle D, Barbeau M. Cost effectiveness of elidel in the management of patients with atopic dermatitis in Canada. J Cutan Med Surg 2004;8: 405-10